Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Tango Therapeutics

Youtube Subscribe

...

Ticker: TNGX

Sector: Biotechnology

Tango Therapeutics, Inc. discovers and develops drugs for the treatment of cancer. Lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5. Company also develops TNG.
...
...
Extended Summary

Tango Therapeutics

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Related Results

...
February 28, 2024 1:29 (London Time)

Tango Therapeutics

GlobalData tracks drug-specific phase transition and likelihood of approval scores. tng-260 by tango therapeutics for non-small cell lung cancer: li…
Sector: Biotechnology
Ticker: TNGX
Sentiment: 0.7351
MarketCap: 1,159,622,843.0
High: 11.95 Low: 11.34

Open: 11.47 Close: 11.8 Change: 0.33

Read more →
...
April 30, 2023 8:08 (London Time)

Tango Therapeutics

Tango Therapeutics chief medical officer Barry Ticho said: “We are advancing a second TANGO ASO into the clinic, which speaks to the potential of ou…
Sector: Biotechnology
Ticker: TNGX
Sentiment: 0.0
MarketCap: 299,914,016
High: 3.56 Low: 3.37

Open: 3.4 Close: 3.4 Change: 0.0

Read more →
...
October 09, 2023 1:11 (London Time)

Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine f…
Sector: Biotechnology
Ticker: TNGX
Sentiment: 0.0772
MarketCap: 1,156,766,108.0
High: 12.43 Low: 11.37

Open: 11.94 Close: 11.38 Change: -0.56

Read more →
Search
Happening Now
Categories